1-103617585-C-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PP3_ModerateBS2
The NM_000699.4(AMY2A):āc.145C>Gā(p.Pro49Ala) variant causes a missense change. The variant allele was found at a frequency of 0.00055 in 1,600,576 control chromosomes in the GnomAD database, including 82 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00037 ( 6 hom., cov: 31)
Exomes š: 0.00057 ( 76 hom. )
Consequence
AMY2A
NM_000699.4 missense
NM_000699.4 missense
Scores
7
8
4
Clinical Significance
Conservation
PhyloP100: 5.55
Genes affected
AMY2A (HGNC:477): (amylase alpha 2A) This gene encodes a member of the alpha-amylase family of proteins. Amylases are secreted proteins that hydrolyze 1,4-alpha-glucoside bonds in oligosaccharides and polysaccharides, catalyzing the first step in digestion of dietary starch and glycogen. This gene and several family members are present in a gene cluster on chromosome 1. This gene encodes an amylase isoenzyme produced by the pancreas. [provided by RefSeq, Jan 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.873
BS2
High Homozygotes in GnomAd4 at 6 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AMY2A | NM_000699.4 | c.145C>G | p.Pro49Ala | missense_variant | 1/10 | ENST00000414303.7 | NP_000690.1 | |
AMY2A | XM_047418085.1 | c.145C>G | p.Pro49Ala | missense_variant | 2/11 | XP_047274041.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AMY2A | ENST00000414303.7 | c.145C>G | p.Pro49Ala | missense_variant | 1/10 | 1 | NM_000699.4 | ENSP00000397582 | P1 | |
AMY2A | ENST00000423678.2 | c.145C>G | p.Pro49Ala | missense_variant | 1/4 | 3 | ENSP00000390832 |
Frequencies
GnomAD3 genomes AF: 0.000366 AC: 55AN: 150232Hom.: 6 Cov.: 31
GnomAD3 genomes
AF:
AC:
55
AN:
150232
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000332 AC: 83AN: 249912Hom.: 6 AF XY: 0.000348 AC XY: 47AN XY: 135078
GnomAD3 exomes
AF:
AC:
83
AN:
249912
Hom.:
AF XY:
AC XY:
47
AN XY:
135078
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000570 AC: 826AN: 1450344Hom.: 76 Cov.: 31 AF XY: 0.000587 AC XY: 424AN XY: 721768
GnomAD4 exome
AF:
AC:
826
AN:
1450344
Hom.:
Cov.:
31
AF XY:
AC XY:
424
AN XY:
721768
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000366 AC: 55AN: 150232Hom.: 6 Cov.: 31 AF XY: 0.000341 AC XY: 25AN XY: 73262
GnomAD4 genome
AF:
AC:
55
AN:
150232
Hom.:
Cov.:
31
AF XY:
AC XY:
25
AN XY:
73262
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
4
ALSPAC
AF:
AC:
7
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
5
ExAC
AF:
AC:
43
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 29, 2021 | The c.145C>G (p.P49A) alteration is located in exon 1 (coding exon 1) of the AMY2A gene. This alteration results from a C to G substitution at nucleotide position 145, causing the proline (P) at amino acid position 49 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
D;D
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;.
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
M;M
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
.;D
REVEL
Pathogenic
Sift
Pathogenic
.;D
Sift4G
Pathogenic
D;D
Polyphen
D;D
Vest4
MVP
MPC
0.56
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at